Products
Available generic and biosimilar medicines
WITH MORE TO COME
MaxRP™
CivicaScript’s MaxRP™ policy is our maximum recommended price to the consumer.
A QR code on every CivicaScript product label enables healthcare providers, caregivers, patients and others to compare prices and confirm they are being charged no more than the MaxRP. If you paid more than the MaxRP, please contact us >
THE CIVICA
INSULIN INITIATIVE
CivicaScript is working with Civica and numerous partners to bring affordable biosimilar insulin to market.
Adverse events
For adverse event reporting, product quality complaints or medical information, please call CivicaScript at 1-833-224-2004 or the FDA at 1-800-FDA-1088 or visit fda.gov/medwatch.
Returns
Learn about CivicaScript’s Customer Product Returns Policy here >
CivicaScript model delivers significant patient and payer savings. Learn more >
